Search

Nita M. Minnifield

Examiner (ID: 17178, Phone: (571)272-0860 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1817, 1621, 1645, 1802, 1813
Total Applications
1564
Issued Applications
1017
Pending Applications
126
Abandoned Applications
425

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15264839 [patent_doc_number] => 20190381153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => BOTULINUM NEUROTOXINS WITH MODIFIED LIGHT CHAIN SPECIFITY AND METHODS FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/557450 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557450 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/557450
Botulinum neurotoxins with modified light chain specificity and methods for producing same Aug 29, 2019 Issued
Array ( [id] => 15290777 [patent_doc_number] => 20190388524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => TREATMENT AND DETECTION OF TRYPANOSOMES [patent_app_type] => utility [patent_app_number] => 16/503687 [patent_app_country] => US [patent_app_date] => 2019-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11476 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503687 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/503687
TREATMENT AND DETECTION OF TRYPANOSOMES Jul 4, 2019 Abandoned
Array ( [id] => 17329275 [patent_doc_number] => 11219717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-11 [patent_title] => Botulinum toxin prefilled plastic syringe [patent_app_type] => utility [patent_app_number] => 16/459382 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11432 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459382 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/459382
Botulinum toxin prefilled plastic syringe Jun 30, 2019 Issued
Array ( [id] => 17236872 [patent_doc_number] => 11180744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Acinetobacter lysins [patent_app_type] => utility [patent_app_number] => 16/454045 [patent_app_country] => US [patent_app_date] => 2019-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 37 [patent_no_of_words] => 12973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454045 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/454045
Acinetobacter lysins Jun 25, 2019 Issued
Array ( [id] => 15035585 [patent_doc_number] => 20190328797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING BACTEROIDES ACIDIFACIENS AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 16/443501 [patent_app_country] => US [patent_app_date] => 2019-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443501 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/443501
Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient Jun 16, 2019 Issued
Array ( [id] => 14990937 [patent_doc_number] => 20190314426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS [patent_app_type] => utility [patent_app_number] => 16/427899 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427899 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/427899
Human-derived bacteria that induce proliferation or accumulation of regulatory T cells May 30, 2019 Issued
Array ( [id] => 14926351 [patent_doc_number] => 20190298813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY [patent_app_type] => utility [patent_app_number] => 16/416758 [patent_app_country] => US [patent_app_date] => 2019-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416758 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/416758
PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY May 19, 2019 Abandoned
Array ( [id] => 16414724 [patent_doc_number] => 10822601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell [patent_app_type] => utility [patent_app_number] => 16/394951 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 53193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394951 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/394951
Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell Apr 24, 2019 Issued
Array ( [id] => 14994451 [patent_doc_number] => 20190316183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE [patent_app_type] => utility [patent_app_number] => 16/390575 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390575 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/390575
FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE Apr 21, 2019 Abandoned
Array ( [id] => 16650002 [patent_doc_number] => 10927165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Antibodies that neutralize botulinum neurotoxins [patent_app_type] => utility [patent_app_number] => 16/389705 [patent_app_country] => US [patent_app_date] => 2019-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 13 [patent_no_of_words] => 40139 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389705 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/389705
Antibodies that neutralize botulinum neurotoxins Apr 18, 2019 Issued
Array ( [id] => 15724323 [patent_doc_number] => 10610576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-07 [patent_title] => Precision glycoconjugates as therapeutic tools [patent_app_type] => utility [patent_app_number] => 16/362363 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 57 [patent_no_of_words] => 28703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362363 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/362363
Precision glycoconjugates as therapeutic tools Mar 21, 2019 Issued
Array ( [id] => 14566919 [patent_doc_number] => 20190211066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 16/360085 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360085 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360085
VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS Mar 20, 2019 Abandoned
Array ( [id] => 14808779 [patent_doc_number] => 20190270999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT [patent_app_type] => utility [patent_app_number] => 16/298715 [patent_app_country] => US [patent_app_date] => 2019-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12222 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/298715
METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT Mar 10, 2019 Abandoned
Array ( [id] => 14682369 [patent_doc_number] => 20190240299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => Suture Line Administration Technique Using Botulinum Toxins [patent_app_type] => utility [patent_app_number] => 16/291383 [patent_app_country] => US [patent_app_date] => 2019-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291383 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/291383
Suture line administration technique using botulinum toxins Mar 3, 2019 Issued
Array ( [id] => 17490630 [patent_doc_number] => 11279922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Delivery of therapeutic agents by a collagen binding protein [patent_app_type] => utility [patent_app_number] => 16/283468 [patent_app_country] => US [patent_app_date] => 2019-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 52 [patent_no_of_words] => 14262 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283468
Delivery of therapeutic agents by a collagen binding protein Feb 21, 2019 Issued
Array ( [id] => 17307332 [patent_doc_number] => 11208424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 16/274822 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19471 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274822 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274822
None Feb 12, 2019 Issued
Array ( [id] => 15321163 [patent_doc_number] => 20200000911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => IMMUNOGENIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/268287 [patent_app_country] => US [patent_app_date] => 2019-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268287 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/268287
IMMUNOGENIC COMPOSITION Feb 4, 2019 Abandoned
Array ( [id] => 16695514 [patent_doc_number] => 10946083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Anti-microbial immunomodulation [patent_app_type] => utility [patent_app_number] => 16/264040 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 35747 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/264040
Anti-microbial immunomodulation Jan 30, 2019 Issued
Array ( [id] => 14621841 [patent_doc_number] => 20190224288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A [patent_app_type] => utility [patent_app_number] => 16/252972 [patent_app_country] => US [patent_app_date] => 2019-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5149 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252972 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/252972
Therapeutic use of the botulinum neurotoxin serotype A Jan 20, 2019 Issued
Array ( [id] => 16695517 [patent_doc_number] => 10946086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Group B [patent_app_type] => utility [patent_app_number] => 16/245378 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 47493 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/245378
Group B Jan 10, 2019 Issued
Menu